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Background: The gap between research and practice or policy is often described as a problem. To identify new
barriers of and facilitators to the use of evidence by policymakers, and assess the state of research in this area, we
updated a systematic review.
Methods: Systematic review. We searched online databases including Medline, Embase, SocSci Abstracts, CDS,
DARE, Psychlit, Cochrane Library, NHSEED, HTA, PAIS, IBSS (Search dates: July 2000 - September 2012). Studies were
included if they were primary research or systematic reviews about factors affecting the use of evidence in policy.
Studies were coded to extract data on methods, topic, focus, results and population.
Results: 145 new studies were identified, of which over half were published after 2010. Thirteen systematic reviews
were included. Compared with the original review, a much wider range of policy topics was found. Although still
primarily in the health field, studies were also drawn from criminal justice, traffic policy, drug policy, and partnership
working. The most frequently reported barriers to evidence uptake were poor access to good quality relevant
research, and lack of timely research output. The most frequently reported facilitators were collaboration between
researchers and policymakers, and improved relationships and skills. There is an increasing amount of research into
new models of knowledge transfer, and evaluations of interventions such as knowledge brokerage.
Conclusions: Timely access to good quality and relevant research evidence, collaborations with policymakers and
relationship- and skills-building with policymakers are reported to be the most important factors in influencing the
use of evidence. Although investigations into the use of evidence have spread beyond the health field and into more
countries, the main barriers and facilitators remained the same as in the earlier review. Few studies provide clear
definitions of policy, evidence or policymaker. Nor are empirical data about policy processes or implementation of policy
widely available. It is therefore difficult to describe the role of evidence and other factors influencing policy. Future
research and policy priorities should aim to illuminate these concepts and processes, target the factors identified in this
review, and consider new methods of overcoming the barriers described.Background
Despite an increasing body of research on the uptake and
impact of research on policy, and encouragement for pol-
icymaking to be evidence-informed [1], research often
struggles to identify a policy audience. The research-policy
‘gap’ is the subject of much commentary and research ac-
tivity [2-4]. Interventions to bridge this gap are the focus
of recent systematic reviews [5-7]. To ensure these inter-
ventions are appropriately designed and effective, it is im-
portant that they address genuine barriers to research* Correspondence: Kathryn.oliver@manchester.ac.uk
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reproduction in any medium, provided the oruptake, and utilise facilitators which are likely to affect re-
search uptake.
It is now well recognized that policy is determined as
much by the decision-making context (and other influ-
ences) as by research evidence [8,9]. Policymakers’ percep-
tions form an important part of this story, but not the
whole. Innvaer [10] aimed to review studies about the
health sector, but the influence of the evidence-based pol-
icy movement is now recognized to be important across
many policy areas. In the UK, with the creation of Clinical
Commissioning Groups, Health and Well-Being Boards,
and private providers moving into areas traditionally occu-
pied by the NHS, a broader range of policymakers are be-
coming potential ‘evidence-users’ than ever. Researcherstd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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policy, what we don’t know, and what can be done to as-
sist these users.
The last systematic review looking at policymakers’ per-
ceptions about the barriers to, and facilitators of research
use was Innvaer [10]. The findings from this review were
corroborated by later research [11,12], but no systematic
update has yet been undertaken. In addition to updating
this review in the area of policymakers’ perceptions of bar-
riers and facilitators to use of evidence in policy, we also
wished to include perceptions from other stakeholder
groups than policymakers, such as researchers, managers,
and other research users. Furthermore, it may be possible
to identify factors affecting research use without relying
on the perceptions of research participants – for example,
ethnographic studies may produce observational data
about knowledge exchange. In addition, we acknowledge
that interest in using evidence to inform policy has spread
beyond the health sector. Therefore, we aimed to update
Innvaer [10] to include studies identifying all barriers and
facilitators of the use of evidence in all policy fields.
This review aimed to update and expand Innvaer [10],
and broaden the scope of the review to:
 Identify factors which act as barriers to and facilitators
of the use of evidence in public policy, including
factors perceived by different stakeholder groups.
 Describe the focus, methods, populations, and
findings of the new evidence in this area.
Because this review has a larger scope that Innvaer [10],
caution must be used in drawing direct comparisons; dis-
cussed further in the results.
Methods
A protocol for the review was developed and sent to an
advisory group of senior academics (available from KO) in
order to ensure that the methods and search strategies
were exhaustive.
To be included, studies had to be:
 Primary research (any study design) or systematic
reviews categorising, describing or explaining how
evidence is used in policymaking. Intervention
studies were included.
 About policy (defined as decisions made by a state
organisation, or a group of state organisations, at a
national, regional or conurbation level). Studies of
clinical decision-making for individual patients, or
protocols for single clinical sites were excluded.
 About barriers or facilitators to the use of evidence
(relational, organisational, factors related to
researchers, policymakers, policy or research
directly, or others).We did not exclude any studies on the basis of popula-
tion. These criteria are therefore broader than those for
Innvaer [10] by including all study designs, all populations
and all policy areas.
The following electronic databases were searched using
adapted search strings from Innvaer [10] from July 2000
(the cut-off point for the earlier review) - September 2012:
Medline, Embase, SocSci Abstracts, CDS, DARE, Psychlit,
Cochrane Library, NHSEED, HTA, PAIS, IBSS. Searches
combined ‘policy’ terms with ‘utilisation/use’ terms in the
first instance. The full search strategy is available from the
corresponding author on request; sample search available
here (Additional file 1). Authors in the field were con-
tacted and key websites were hand-searched. In order to
pick up a range of study designs and theoretical papers a
methodological filter was not applied.
All studies were screened initially on title and abstract.
100 studies were double screened to ensure consistency,
and revisions were made to definitions and criteria ac-
cordingly. Relevant studies were retrieved and screened
on full text by one reviewer.
Studies were stored, screened and keyworded using
the EPPI Reviewer software [13]. Data were extracted
on study characteristics, sampling and recruitment,
theoretical framework, methods, and results, with all
studies being coded by one reviewer, and two reviewers
coding 10-25% each (67 studies were double-coded in
total). Because we were not aiming to determine the
size of an effect, but instead to describe a body of litera-
ture, no risk of bias assessment was made. Quality ap-
praisal in this case would have made no difference to
this systematic descriptive synthesis.
Studies were keyworded using a data extraction tool
which collected information on study characteristics, topic
and focus, and theoretical background. Factors which af-
fected evidence use were coded as barriers or facilitators
against a pre-defined list of factors, which was iteratively
updated as new factors were identified. All studies were
therefore coded at least twice, once with the initial tool,
and once with the finalised list of factors.
Results
6879 unique records were retrieved, of which 430 were
screened on full text. 145 studies were included on full
text, of which half were published between September
2010 and September 2012. Figure 1 describes the flow of
studies through searching and screening for inclusion.
Characteristics of included studies
For a full description of the included studies, see Additional
file 2. Studies were undertaken in a wide range of countries
(145 studies in over 59 countries,). A significant proportion
(n = 33, 23%) were from low- and middle-income countries
in regions such as sub-Saharan Africa and Central America
Figure 1 PRISMA flowchart detailing flow of studies through the review.
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states (n = 4).
Eleven studies used observational (ethnographic)
methods to collect data, and 37 used documentary ana-
lysis. However, these represent less than a quarter of in-
cluded studies, the majority of which were or included
semi-structured interviews (n = 79), or included a sur-
vey (n = 44). Twelve studies were longitudinal while the
rest were cross-sectional. Thirteen systematic reviews and
fifty-three case studies were included.
Most studies reported perceptions or experiences of re-
spondents (n = 109; n = 64 respectively), rather than docu-
mentary proof or observational results about the use of
evidence in policy (n = 14; n = 11 respectively). ‘Evidence’
was defined in 121 studies. Where it was possible to iden-
tify what kinds of evidence were being discussed, most fo-
cused on the use of research evidence (n = 90) with 33
focusing specifically on systematic reviews. However, 59
studies looked at the use of non-formal evidence, which
included local data, surveillance data, personal experience,
clinical expertise, or other informal knowledge.
The context of the study was usually non-specific, refer-
ring to general policy (n = 84) or practice (n = 37).Changes to specific policy areas or policies were explored
in 22 and 14 studies respectively, and information/evi-
dence diffusion in 13. Some studies explicitly set out to
look at uptake or adoption of research (n = 41), and others
described interventions aiming to increase uptake [14], or
the context after a specific piece of research or policy
(such as after the introduction of the 1999 White Paper
“Saving Lives: our healthier nation” [15,16]. The vast
majority of studies were conducted in health or health-
related fields. Most new evidence in the area focused on
the health sector, but research was also conducted in
areas including traffic [17,18], criminal justice [19-23],
drugs policy [22,24-37], and environmental conservation
[20,22,38-42] (see Figure 2).
Who are these studies written by and for?
137 study reports were written by researchers or people
with academic affiliations, with clinical researchers co-
authoring a proportion of these (n = 57). Policymakers
were credited as authors in 3 studies, [25,39,43] and one
of those was a governmental report.
The population samples themselves were predominantly
policymakers or advisors (n = 86, n = 32 respectively),
Figure 2 Policy focus of study.
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many other groups were also included (see Figure 3).
Where researchers were included in the study population
(n = 49), they often outnumbered the policy and practice
participants. Other participants included commissioners,
health economists, third sector workers, patients, industry
and business representatives, and justice and criminal
workers. Because it was not always clear who had been in-
volved and what their roles were, it was not possible to give
numbers for all these groups. Also included in this ‘other’
category (n = 62) were all documents analysed.
What factors affect use of evidence?
All studies reported either barriers, facilitators, or both,
of the use of evidence. Studies also described processes
of research use (n = 50), strategies and interventions to
increase research use (n = 24), and assessments of the
uptake of research (n = 33) (see Figure 4).
Studies reported a range of factors which acted as barriers
and/or facilitators of evidence use. The most frequently re-
ported barriers were the lack of availability to research, lack
of relevant research, having no time or opportunity to use
research evidence, policymakers’ and other users not being
skilled in research methods, and costs (see Table 1). The
most frequently reported facilitators also included access to
and improved dissemination of research, and existence of
and access to relevant research. Collaboration and relation-
ships between policymakers and research staff were all re-
ported as important factors.To interpret all the factors reported by included
studies, the barriers and facilitators were categorised
into themes depending on content: ‘Organisations and
resources’, ‘Contact and collaboration’, ‘Research and
researcher characteristics’, ‘Policymaker characteris-
tics’, ‘Policy characteristics’, and ‘Other’ (see Table 2).
Below, we describe the main barriers and facilitators
reported within each theme, and we give some supple-
mentary information not mentioned in the table.
Contact and relationships
Contact, collaboration and relationships are a major fa-
cilitator of evidence use, reported in over two thirds of
all studies. Timing and opportunity was the most prom-
inent barrier (n = 42) within this theme. Many studies
also discussed the role of relationships, trust, and mutual
respect. The serendipitous nature of the policy process
was emphasised in some studies, which discussed the
role of informal, unplanned contact in policy develop-
ment and in finding evidence.Organisations and resources
Organisational factors such as lack of access to research,
poor dissemination and costs were highly reported fac-
tors affecting the use of research. Other barriers were
lack of managerial support, professional bodies, material
and personnel resources, managerial will and staff turn-
over. Professional bodies were seen as barriers where
Figure 3 Sample population.
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perceived to be political or biased. In the case of the
WHO, it was seen as unreliable, unsupportive, and with
dubious claims to be ‘evidence-based’ [31,44]. Other
factors mentioned in connection with organisationalFigure 4 Main barriers and facilitators of the use of evidence by policand resource barriers included poor long term policy
planning [45], inflexible and non-transparent policy
processes [46,47] and in developing countries, lack of
effective health care systems [24]. Leadership and au-
thority were reported as facilitators, with emphasis onymakers.
Table 1 Most frequently reported barriers and facilitators of the use of evidence (n = # studies in which factor reported)
Top 5 barriers to use of evidence Top 5 facilitators of evidence use
• Availability and access to research/improved dissemination (n = 63) • Availability and access to research/improved dissemination (n = 65)
• Clarity/relevance/reliability of research findings (n = 54) • Collaboration (n = 49)
• Timing/opportunity (n = 42) • Clarity/relevance/reliability of research findings (n = 46)
• Policymaker research skills (n = 26) • Relationship with policymakers (n = 39)
• Costs (n = 25) • Relationship with researchers/info staff (n = 37)
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of policy champions [43,49].
Among the facilitators under the theme Organisation
and Resources, availability, access and dissemination
were considered important facilitators, as was managerial
support (n = 22).
Research and researcher characteristics
Characteristics of research evidence were widely re-
ported as factors affecting uptake of research, with clar-
ity, relevance and reliability of research findings reported
as important factors. The format of research output was
also an important factor in uptake. The importance of
the research findings themselves was discussed in 19
studies, usually studies describing the uptake of health
inequalities research. The quality and authoritativeness
of research was clearly a factor in uptake, particularly
where other evidence in the area was poor quality [50].
Emerging as a new stream of research, eleven studies
evaluated or described knowledge broker roles or related
concepts [6,35,37,51-57] with dedicated dissemination
strategies evaluated in 7 studies and mentioned as a facili-
tator in 43. Incentives to use evidence and client demand
for research evidence were described as facilitators in one
study each [10,58].
Researchers themselves were described as factors
affecting uptake of their research. Having a good un-
derstanding of the policy process and the context sur-
rounding policy priorities was supportive of research
uptake [17,18,59-61]. A barrier to uptake was identified
where researchers were described as having different pri-
orities from policymakers, with pressure to publish in
peer-reviewed journals [27,62,63]. Researchers were valued
more when it was clear they were non-partisan and produ-
cing unbiased results [40,57,64], and provision of expert
advice was also reported as helpful.
Policymaker characteristics
Policymakers’ characteristics were also reported to play a
role in evidence uptake, with their research skills and
awareness (or lack of) reported as a barrier in 34 studies.
Some studies reported that policymakers’ beliefs about the
utility of evidence-use was a major factor in evidence use
(barrier: n = 2, facilitator: n = 3), and, in general, personal
experiences, judgments, and values were reported asimportant factors in whether evidence was used. However,
these findings were nearly all (91%) based on studies of
perceptions, of which half were perceptions of researchers.
Some studies reported that left-leaning, younger and/
or female policymakers were more likely to use research
evidence [65,66]. Being more highly educated was re-
ported as a barrier [67], but there was no consensus
about the effect of being clinically trained [61,68].
Policy characteristics
Perhaps surprisingly, legal support and the existence of
guidelines for the use of evidence were scarcely reported
as factors affecting uptake of evidence. The importance
and complexity of the policy area was also discussed, es-
pecially in comparison with the relative simplicity of
clinical problems.
However, competing pressures (economic, political, so-
cial, and cultural factors) were seen to impact on the pol-
icy process and hinder the development of evidence-based
policy. Political pressures, finances, and competing prior-
ities were all discussed (n = 12), with the media (n = 3)
vested interest and pressure/lobby groups (n = 3) and un-
clear decision-making practices (n = 2) also reported as
barriers.
Other factors
One study which studied use of evidence in prisons re-
ported potential security breaches from data loss as a po-
tential barrier to evidence use [19]. Other studies reported
consumer-related barriers (such as issues around privacy
and choice [49,55,69]), differences between types of policy-
maker (such as civil servants vs. managers) [29,70] and
public opinion. External events were reported as a facilita-
tor in one study. The role of local context, contingency,
and serendipity in influencing policy processes and out-
comes overall emerged as a theme throughout the results.
Comparing with Innvaer (2002): focus of new evidence in
the area
There are differences between the reviews (see Table 3), in
part reflecting the broader inclusion criteria for this up-
date. However, it is clear that interest in studying the use
of evidence has spread beyond the health sector, with
more attention from other public policy domains. In
addition, there is an increase in publications from low-and
Table 2 Barriers and Facilitators categorised into themes (n = number of studies)
Seen as barrier Factor Seen as facilitator
85 Contact and collaboration 98
8 Collaboration 49
42 Timing/opportunity 24
8 Relationship with policymakers 39
8 Relationship with researchers/info staff 37
8 Contact with researchers/info staff 31
9 Contact with policymakers 30
2 Other 1
92 Organisation and resources 99
63 Availability and access to research/improved dissemination 65
25 Costs 11
3 Managerial support (practical) 22
11 Professional bodies 15
11 Material resources available 12
14 Staff or personnel resources 10
3 Managerial will 5
9 Staff turnover/continuity of employment 3
9 Other 9
85 Research and researcher characteristics 95
54 Clarity/relevance/reliability of research findings 46
18 Format of research findings 26
9 Importance of research findings 10
25 Other 32
62 Policymaker characteristics 69
26 Policymaker research skills 22
24 Policymaker research awareness 10
13 Political support (will) 21
4 Political support (practical) 12
12 Practitioner research skills 6
3 Practitioner research awareness 2
6 Other 11
28 Policy characteristics 33
6 Guidelines or policy statement 9
9 Importance of policy 11
5 Legal or legislative support 3
26 Other pressures on policy 5
4 Other 4
10 Other 1
9 Consumer-related barrier 0
1 Other 1
105 All factors (total) 124
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Table 3 Comparing the two reviews
Innvaer [10] Current systematic review
Number of studies 24 145
Study designs Mainly small survey and interview-based
studies of policymakers’ perceptions
Mainly small survey and interview-based studies of
policymakers’ perceptions with a minority of in-depth case studies
Policy domains All health Mainly health, but with studies from a wide range of policy contexts
Countries Mainly OECD At least 1/3 from LMIC
Main facilitator Personal contact between researchers and PMs Available, clear and relevant research evidence
Timeliness and relevance of research, with
clear recommendations & high quality
Relationships, collaboration & contact between researchers and PMs
Research confirming current policy Timing, practical managerial support and
Main barriers Absence of personal contact between
researchers and policymakers
Lack of clear or relevant research evidence, costs
Lack of timeliness or relevance Lack of timeliness or opportunity
Mutual mistrust between scientists and policymakers Lack of PM research skills or awareness
Power and budget struggles
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pressures on policymakers in these countries are likely to
be very different from those in high-income countries.
However, the main research methods used by included
studies, and the results generated by those methods, are
similar. Despite this increase in research attention, there is
still a remarkable dearth of reliable empirical evidence
about the actual processes and impacts of research and
other evidence use in policy.
Discussion
This systematic review aimed to identify and describe re-
search about the barriers and facilitators of the use of
evidence for policy, expanding on and updating Innvaer
[10]. It found that organisational factors, including avail-
ability and access to research were considered to be im-
portant influences on whether evidence was used in
policy, and the quality of the relationship and collabor-
ation between researchers and policymakers to be the
single most mentioned facilitator.
The findings of the updated systematic review pre-
sented here were consistent with the original review. We
can have a high degree of confidence that it is possible
to identify factors likely to influence research uptake, as
the expanded field of research synthesised here demon-
strates. However, it is less clear what we can learn from
this research. For example, there was a high degree of
consistency in the findings, even though studies from
very different contexts were included. It seems plausible
that developing countries would have different barriers
from wealthy countries; or that criminal justice would
have systematically different pressures from health pol-
icy. The similarities reported in these studies may be
accounted for by the similarity in approach and methods
used. Indeed, the impact and contributions of researchto policy (and vice versa) are still unclear, with few stud-
ies exploring how, when and why different facilitators
and barriers come into play during the policymaking
process, or developing an understanding of how research
impact on policy and populations might be evaluated.
However, there are undoubtedly wider questions about
how impact may be defined and measured which are, as
yet, unanswered. While perceptions and attitudes are of
course important to illuminating the policy process, but
there are likely to be other ways - for example documen-
tary, historical, ethnographic or network analyses - in
which the role of evidence could be, unpicked [71].
Over a third of the included studies mentioned use of
informal evidence such as local data or tacit knowledge.
Researchers are starting to recognize that research evi-
dence is just one source of information for policymakers
[72]. Identifying these sources and types of information
are a crucial step in describing and ultimately influen-
cing the policy process. However, most studies do not
define what they mean by ‘evidence’, hampering attempts
to understand the process. Interventions addressing bar-
riers specifically are unlikely to influence policy without
a detailed understanding of all these factors.
Studies in this area continue to be mainly written by
and for researchers, with a lack of attention given to
the policy process or policymakers’ priorities. Most
studies asked researchers about their perspectives.
Where mixed populations were included, the re-
searchers often outnumbered the other participants. In-
volving policymakers in designing and writing a study
which looks at these issues in conjunction with barriers
and facilitators may be fruitful. Until then, it is hard to
defend academics from the charge of misunderstanding
policy priorities or processes – a charge first made ex-
plicit over 20 years ago [73].
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The review is exhaustive, and we followed a pre-published
protocol and rigorous review methods, including the ad-
vice of an advisory group (details available from the corre-
sponding author) (see Additional file 3 for a PRISMA
checklist report). However, this paper has only counted
the frequencies with which factors are mentioned without
any weighting. Without more research, it is difficult to say
what impact different factors might have.
Most studies still employ relatively superficial methods
such as surveys or short interviews. These were all based
on self-reports, however, so given the contentious nature
of the topic combined with understandable fear of audit/
performance monitoring these results may not be reliable.
However, there is some evidence that researchers are
employing impact assessment, intervention, or observa-
tional studies as well to explore how evidence and policy
are related. We were unable to double-screen and double-
code all studies due to lack of resources. However, all
studies were data-extracted at least twice (once at the be-
ginning, and again with the finalized list of factors which
was developed iteratively) so we have confidence in the
consistency of approach. No methodological assessment
of included studies was undertaken, as this was primarily a
descriptive exercise. In addition, the heterogeneity of study
designs and the difficulty of comparing quality across
these domains limited the usefulness of such an exercise.
Quality appraisal would be a valuable step in any in-depth
review of a subset of these studies.
Strengths and weaknesses in relation to other studies
Recent systematic reviews in the area have focused on the
use of research evidence, [74] or on the impact of research
evidence on policy [5]. Orton [75], included in this review,
does not include any evaluations of evidence use, ethnog-
raphies, or case studies, relying only on self-report ques-
tionnaires and interviews to provide the results. Without
empirical data exploring access to information and per-
ceived impact [74], and without investigating the policy
process, or testing current theories about knowledge
utilization, it is hard to draw useful conclusions. Few stud-
ies have systematically appraised the use of evidence in this
wider sense.
The reviews all found similar findings with regard to
barriers and facilitators of the use of evidence. There still
appears to be a need for high-quality, simple, clear and
relevant research summaries, to be delivered by known
and trusted researchers.
Possible change in future research practice
and policymaking
Most studies in this review are descriptive. Because most
studies do not go into the content of the facilitators and
barriers they identified, we know little about when, whyand how the identified barriers and facilitators come into
play in the use of evidence in policymaking. Based on
this review, future research can use Table 2 to identify
themes and factors relevant for their field of research, be
it organisations, collaboration, research, researchers, pol-
icymakers or policy. Identifying the content and relative
importance of these factors and new undiscovered fac-
tors in different contexts, at different levels, or in differ-
ent countries, may contribute to our understanding of
evidence use in policy.
One future objective for researchers can be drawn from
the results found in Table 1, namely that four of the five
top barriers to the use of evidence is a lack of relevance
and importance. If research becomes available, the possi-
bility of increased use improves. If policymakers’ research
skills improve, calculations of costs will become more ac-
curate. The natural question is to explore why policy-
makers do not prioritize overcoming barriers relating to
themselves. The barrier called lack of clarity, relevance
and reliability of research calls for change in researchers’
objectives and methods, but we need to know what policy-
makers define as clear, relevant and reliable research, and
why and when policymakers will use such research. Of
special relevance to this question, is the research on know-
ledge translation done in the past five to ten years, which
formed a new strand of research. This body of work draws
on the theory that interpersonal relations are important
for knowledge exchange, through employing knowledge
brokers or similar. There has also been a growth in re-
sources aimed at helping decision-makers to navigate
research evidence, such as Cochrane-produced evidence
summaries. These are not only aimed at practitioners
within the health field, and the knowledge translation field
will hopefully soon make efforts at addressing the broader
issues around evidence use in policy more widely to iden-
tify underlying mechanisms behind knowledge use.Conclusion
This review looked for all barriers and facilitators of the
used of evidence in policy. Most studies collected re-
search and policy actors’ perceptions about factors affect-
ing the use of research evidence, with a large minority
surveying only researchers. Understanding how to allevi-
ate these barriers is hampered by a lack of clarity about
how ‘evidence’ is defined by studies, with fewer than half
specifying what kinds of information were discussed. Most
studies however focused on uptake of research evidence,
as opposed to evidence more widely. Research into how to
alleviate organisational and resource barriers effectively
would be welcomed. Additionally, all such research should
be based on an understanding that a broader interpret-
ation of “evidence” than “research-based” evidence is also
essential.
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ments of the policy process. However, few studies use ded-
icated relational methods such as network analysis to
study policy communities or the policy process, with a few
exceptions [75,76].
Several new strands of research offer encouragement
to researchers in the area. Firstly, learning from political
sciences and management studies is filtering into the
EBP debates, as can be seen from the attention paid to
leadership and organisational factors. Research into pol-
icy entrepreneurship and knowledge brokerage also
formed a significant subset of studies. However, there re-
mains a need for empirical evidence to be generated
about the policy process. The barriers and facilitators
generated above refer specifically to the use of evidence;
however, it is equally possible that similar factors affect
the policy process in general (for example, constraints
on resources, personnel and costs are likely to affect all
policy decisions). Identification and exploration of all
factors influencing policy, not just those relating to evi-
dence, should be of interest to researchers; however, this
is outside the scope of this review.
Finally, little empirical evidence about the processes or
impact of the use of evidence by policy is presented by
these studies. Despite the increased amount of research
on interventions to increase research use in policy, this
is not linked with research about the impact of policy on
populations, or of evidence use on population outcomes.
Much of the literature is concerned with policymaking;
but policymakers’ time is spend on implementation. To
justify the continuing rhetoric about the importance of
research use, and the ever-increasing amount of research
into the area, it is surely essential that we practise what
we preach and generate evidence about the process and
effectiveness of research use in policy.
“What this paper adds” box
Section 1: What is already known on this subject
Little is known about the role of research in policymaking.
A previous systematic review (Innvaer [10]) identified the
main barriers and facilitators of the use of evidence. Al-
though subsequent reviews have been conducted, they
have focused on specific types of evidence, such as eco-
nomic analyses (Williams) or systematic reviews (Best), or
on first-world countries (Orton). Given the explosion of
research in the area, an update of the original review was
carried out.
Section 2: What this study add
The most often mentioned facilitators of the use of evi-
dence are still reported to be relationships, contact and col-
laboration, availability and access to research, and relevant,
reliable and clear research findings. A lack of relevant, reli-
able and clear research findings, and poor availability andaccess to research, are the most often mentioned barriers
to policymakers’ use of research.
Research into EBP has spread across a wide range of pol-
icy areas and countries, including those from low and
middle-income countries. New strands of research focus on
knowledge translation, knowledge brokerage, and other in-
terventions to increase uptake of evidence. Little research
exists about the process, impact or effectiveness of how,
when and why research is used during the policy process.
This study did not require ethics approval.
Data sharing: Full dataset and search strategies are
available from Kathryn Oliver at Kathryn.oliver@man-
chester.ac.uk. Consent was not obtained as this study
had no participants.Additional files
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